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Abstract
This work investigates the difference in viability of primary human foetal osteoblast cells on
a glass-ceramic surface with nanoscale topography relative to viability on a smooth glassceramic surface containing a bioactive phase. Apatite-mullite glass-ceramics containing
bioactive fluorapatite (Ca10(PO4)6F2) and bioinert mullite (Si2Al6O13) were synthesised and
subsequent heat-treatment was optimised to form nano-sized fluorapatite crystals. Etching
was used to selectively remove the bioactive phase, producing a surface with disordered
nanoscale topography. Cells were seeded onto a smooth polished glass-ceramic substrate with
the bioactive phase intact, an etched nanostructured glass-ceramic with the bioactive phase
removed, and a borosilicate glass control. Cell viability after 24 h and 48 h was significantly
greater on the nanostructured surface compared to the smooth bioactive surface, while cell
viability at both time points was significantly greater on both nanostructured and smooth
bioactive surfaces compared to the control.
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1

Introduction

The fixation of orthopaedic implants to surrounding tissue can be greatly improved by
promotion of osteointegration [1]. The surface chemistry of implants has been shown in many
studies to influence osteointegration [2, 3], and bioactive surface coatings such as
hydroxyapatite are therefore commonly applied [3]. Apatite-mullite glass-ceramics (AMGCs)
are being investigated as an alternative surface coating [4]. AMGCs are triphasic materials
composed of fluorapatite (Ca10(PO4)6F2) and mullite (Si2Al6O13) in a residual glass matrix
[5]. Fluorapatite is bioactive and promotes cellular attachment [6, 7] and the presence of
fluoride ions promotes bone regeneration [8].
Surface topography at the nanoscale has been shown in many studies to significantly
influence osteoblast attachment, adhesion, proliferation, and differentiation on a range of
biomaterials [9-12]. Nanoscale disordered topographies using polymethylmethacrylate
(PMMA) substrates have been shown by Dalby et al. to stimulate mesenchymal stem cells
(MSCs) to proliferate, differentiate and produce more bone mineral than MSCs seeded onto
smooth PMMA substrates [11], demonstrating that surface topography can have significant
biological effects.
The crystallisation [13] of AMGCs can be controlled such that only nano-sized fluorapatite
crystals are formed. Such AMGCs offer the potential to create nanoscale topography similar
to those presented by Dalby et al. [11] by selective etching of the fluorapatite phase at the
glass-ceramic surface [14]. However, given that fluorapatite is the phase that is typically
etched, the topography is produced by removing the bioactive phase from the surface. This
provides a novel opportunity to compare the influences of surface chemistry and surface
topography on cell viability: the influence surface chemistry can be examined by seeding
cells onto an AMGC with the bioactive phase present, with the influence of topography
examined by seeding cells onto a disordered nanoscale topography created by removing the
bioactive phase.
Immortalised cell lines are widely used in cell culture studies [15]. However, here, for better
clinical relevance, primary cells are used.
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Materials and Methods

A glass with molar composition 4.85SiO2–3.25Al2O3–1.5P2O5–3.25CaO–1.75CaF2, chosen
following a review of previous studies [14, 16, 17], was synthesised by melt-quench, as
previously described [5, 14]. This composition may produce crystal sizes and spatial density
similar to the topographies used by Dalby et al. [11]. Some of the glass was re-melted and
cast to form cylinders (Ø 11 mm) with annealing at Tg − 100 °C (560 °C) [14]. Cast cylinders
were sectioned into 2.5 mm thick discs.
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Glass frit was characterised by differential scanning calorimetry (DSC) [14] to determine the
glass transition temperature (Tg) and primary and secondary crystallization peak temperatures
(Tp1 and Tp2).
Glass-ceramics were formed by heating glass discs at 10 °C/min to a range of temperatures
above Tp2, with dwell periods of 0–60 min, followed by cooling in air. Samples were then
ground and polished to a sub-micron finish [16].
X-ray diffraction (XRD) was carried out to confirm the amorphous nature of cast glass
samples and identify the phases present in heat-treated samples using a Siemens D500
diffractometer (Munich, Germany) with CuK𝛼 X-rays from 10°–70° 2𝜃. Phases were
identified using JCPDS-ICDD PDF cards 15-876 (fluorapatite) and 15-776 (mullite).
Glass-ceramic samples were etched for 20 s in 1 M HNO3, follwed by rinsing in water
followed by ethanol and drying. This removes the fluorapatite phase from the surface, leaving
the bioinert mullite phase and residual glass.
Microscopical analysis was performed to identify the ideal crystallisation temperature and
dwell period for formation a nanostructured surface. Samples were gold sputter coated and
imaged using an FEI Quanta 3D FEG-SEM (Eindhoven, The Netherlands). The average pore
size and spatial density of pores on substrate surfaces were determined using ImageJ [18].
Three different substrate types were used for cell culturing: a smooth polished AMGC, an
etched AMGC, and a borosilicate glass control.
Glass-ceramic samples for cell study were prepared by heat-treating using the ideal
crystallisation temperature and dwell period, as determined by microscopical analysis. For
sterilisation prior to cell culture, substrates were rinsed in ethanol and distilled water, then
covered in aluminium foil and heated to 350 °C for 2 h.
A primary human foetal osteoblast cell line (hFOB 1.19 (ATCC CRL-11372)) was used to
assess the biological performance of the substrates. Routine maintenance of the cell line
involved culturing in a 1:1 mixture of Ham's F12 Medium and Dulbecco's Modified Eagle's
Medium, with 2.5 mM L-glutamine (without phenol red), 0.3 mg/ml G418 and foetal bovine
serum to a final concentration of 10 %. Cells were grown at 34 °C, 5 % CO2, 95 % relative
humidity according to ATCC culture guidelines. A sub-cultivation ratio of 1:4 was used with
medium renewal every 2–3 days.
Cells were seeded onto the substrate discs (5×105 cells/disc) in 24-well plates and cultured for
24 h (n=5) and 48 h (n=6). Supernatant was then removed and wells with discs were washed
with phosphate buffered saline before being placed into new 24-well plates. Cell growth and
viability was assessed using WST-1 (Roche Diagnostics, Basel, Switzerland) according to the
manufacturer's protocol. WST-1 solution was diluted 1:10 in medium and dispensed into the
wells. Plates were incubated for 1 h at 37 °C before absorbance at 440 nm was recorded using
a scanning multiwell spectrophotometer (ELISA reader).
Student t-tests were performed to test for statistical significance using P-values ≤ 0.05.
4
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Results

DSC analysis of the glass revealed a glass-transition onset at 660 °C, and two crystallisation
exotherms, peaking at 790 °C (Tp1) and 1016 °C (Tp2).
XRD profiles for the as-cast glass and an exemplar glass-ceramic produced by heat-treating
to Tp2 are given in Fig. 1. The profile for the glass exhibits an amorphous halo (17–37° 2θ)
with no sharp diffraction peaks, confirming that purely amorphous glass was synthesised and
no devitrification occurred during casting. The profile for the glass-ceramic confirms the
crystallization of fluorapatite and mullite.

Fig. 1 XRD profiles for as-cast glass and AMGC heat-treated at Tp2.
Microscopical analysis revealed that heat-treating to 1100 °C for 20 min produced a glassceramic with appropriate nano-sized fluorapatite crystals (Fig. 2). The pores correspond to
locations of fluorapatite removed by etching, yielding a disordered nanoscale surface
topography. The average pore diameter was 118 ± 53 nm, with a spatial density of
≈ 8 pores/µm2, approximating the topographies of Dalby et al. [11].
Fig. 3 shows the cell viability results. Cells were able to attach to all test surfaces. The
smooth and etched AMGC surfaces exhibited significantly better cell viability than the
control after 24 h and 48 h (P < 0.01). At both time points cell viability was significantly
greater on the etched AMGC surfaces compared with the smooth AMGC surfaces (P < 0.01).
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Fig. 2 Micrographs of AMGC heated to 1100 °C for 20 min and etched.

Fig. 3 Optical density measurements for cell viability on test surfaces after 24 h and 48 h.
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Discussion

After 24 h and 48 h both the smooth and etched surfaces had a significantly greater number
of cells present than the control. Etching of the AMGC to remove the fluorapatite phase
provided a degree of roughness and an increase in surface area compared to the control.
Rough surfaces have been shown to promote cellular attachment by providing more sites for
the adsorption of proteins such as fibronectin, which has been shown to promote cellular
adhesion [19, 20]. The greater cellular attachment and low toxicity of the etched substrates
contributed to the greater cell viability compared to the smooth borosilicate control.
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Although the nanostructured substrates exhibited statistically greater cell viability than the
smooth AMGC substrates, this difference was relatively low after 24 h (8 %–10 %) and did
not increase after 48 h. Given the variability of patient responses and other clinical variables,
it would be prudent to not deem this difference clinically significant.
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Conclusion

AMGCs can be used to create disordered nanoscale topographies by controlled heattreatment and etching of the fluorapatite phase. While these surfaces provide a statistically
significant increase in cell viability compared to a smooth bioactive surface, these effects
may not produce clinically different outcomes in vivo. Expansion of this study to other
bioactive glass-ceramics and other cell lines may determine how universal this effect is.
Acknowledgements: Research funded under PRTLI of HEA Ireland.
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